CHICAGO / Apr 09, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025.
Peter Arduini, president and CEO, GE HealthCare, said, “Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Care Solutions forward and deliver on our precision care strategy.”
Bankes brings with her three decades of global experience including product management, marketing, sales, regulatory, medical affairs, and operations and manufacturing. She joins GE HealthCare from Alcon, where she served most recently as senior vice president and president, Global Franchises. In this role, she oversaw product development, portfolio management and commercialization of products across the global surgical, vision care, and ocular health businesses. Prior to Alcon, Bankes was at Boston Scientific and Merck, where she held a range of senior leadership positions.
Tom Westrick, who is retiring after more than 20 years with GE HealthCare, will remain with the company until May 31, 2025, to support Jeannette’s transition into the role, and help ensure a smooth changeover for our colleagues and customers. Jeannette will be based in Waukesha, Wisconsin.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.
GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.
| Last Trade: | US$80.00 |
| Daily Change: | 1.76 2.25 |
| Daily Volume: | 6,716,569 |
| Market Cap: | US$36.440B |
November 25, 2025 November 24, 2025 November 20, 2025 November 17, 2025 November 16, 2025 | |

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load